Company / CapEx per Share
Kodiak Sciences Inc. CapEx per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.01
FY2024
5-year range
$0.01 / $0.79
FY2020-FY2024
Trend
-99.1%
vs FY2023
Sector context
#129 of 190
Health Care
What the data says
At $0.01, Kodiak Sciences Inc.'s capex per share ranks #129 of 190 in the Health Care sector. Declined from $0.71 to $0.01 over the past 2 years.
Based on SEC 10-K filings.
0.01 in FY2024 with a 5-year CAGR of -9.2%.
Declined from $0.71 to $0.01 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -72.1%
- 5-Year CAGR
- -9.2%
- 10-Year CAGR
- -
Sector benchmark
#129 of 190 in Health CareTop 68% of 190This company $0.01 Sector average $2.49
▼
-99.7% below sector average
Key checks
Key Insights
- In FY2024, capex per share decreased 99.1% year-over-year.
- Ranks #129 out of 190 companies in the Health Care sector.
- Peak capex per share was recorded in FY2023.
- Lowest capex per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.01 | -99.1% |
| FY2023 | $0.79 | +11.3% |
| FY2022 | $0.71 | +115.4% |
| FY2021 | $0.33 | +294.4% |
| FY2020 | $0.08 | +622.3% |
| FY2019 | $0.01 | +121.7% |
| FY2018 | $0.01 | -81.3% |
| FY2017 | $0.03 | -74.0% |
| FY2016 | $0.11 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026